. A novel technology for objective, accurate and non-invasive early diagnosis and monitoring of Alzheimer’s disease in clinics and clinical trials. 2019 Oct 02 10.1101/790469 (version 1) bioRxiv.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. FDA Approves BrainSee, AI Software That Purportedly Predicts AD